These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 15487459)

  • 1. Targeted therapies for cancer 2004.
    Ross JS; Schenkein DP; Pietrusko R; Rolfe M; Linette GP; Stec J; Stagliano NE; Ginsburg GS; Symmans WF; Pusztai L; Hortobagyi GN
    Am J Clin Pathol; 2004 Oct; 122(4):598-609. PubMed ID: 15487459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent advances of molecular targeted agents: opportunities for imaging.
    Dancey JE
    Cancer Biol Ther; 2003; 2(6):601-9. PubMed ID: 14688462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal antibodies as therapeutic agents for cancer.
    Harris M
    Lancet Oncol; 2004 May; 5(5):292-302. PubMed ID: 15120666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in therapy for solid tumors: potential for overcoming drug resistance in vivo with molecular targeting agents.
    Kim R; Toge T
    Surg Today; 2004; 34(4):293-303. PubMed ID: 15052442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidermal growth factor receptor inhibition strategies in oncology.
    Harari PM
    Endocr Relat Cancer; 2004 Dec; 11(4):689-708. PubMed ID: 15613446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted therapies for the treatment of cancer.
    Kim JA
    Am J Surg; 2003 Sep; 186(3):264-8. PubMed ID: 12946830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoclonal antibodies targeting vascular endothelial growth factor: current status and future challenges in cancer therapy.
    Hsu JY; Wakelee HA
    BioDrugs; 2009; 23(5):289-304. PubMed ID: 19754219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Anti-cancer monoclonal antibody].
    Sasaki S; Ishida T; Tsujisaki M; Imai K
    Nihon Rinsho; 2005 Apr; 63 Suppl 4():608-12. PubMed ID: 15861718
    [No Abstract]   [Full Text] [Related]  

  • 9. [Problems in the current target therapy of malignancies].
    Stukov AN; Gershanovich ML; Filov VA; Imianitov EN
    Vopr Onkol; 2005; 51(5):607-11. PubMed ID: 16756022
    [No Abstract]   [Full Text] [Related]  

  • 10. HER-2-positive breast cancer: hope beyond trastuzumab.
    Bartsch R; Wenzel C; Zielinski CC; Steger GG
    BioDrugs; 2007; 21(2):69-77. PubMed ID: 17402790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Targeting ErbB receptors in breast cancer].
    Fumoleau P; Campone M; Coudert B; Mayer F; Favier L; Ferrant E
    Bull Cancer; 2007; 94(7 Suppl):F147-70. PubMed ID: 17964992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trastuzumab: targeted therapy for the management of HER-2/neu-overexpressing metastatic breast cancer.
    Emens LA
    Am J Ther; 2005; 12(3):243-53. PubMed ID: 15891269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody-based therapy for solid tumors.
    Yan L; Hsu K; Beckman RA
    Cancer J; 2008; 14(3):178-83. PubMed ID: 18536557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Molecular diagnosis of solid tumors].
    Yatabe Y
    Nihon Rinsho; 2005 Mar; 63(3):434-40. PubMed ID: 15773342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Molecular targeted therapies for metastatic breast cancer. Monoclonal antibodies and tyrosine kinase inhibitors].
    Nielsen DL; Andersson M
    Ugeskr Laeger; 2007 Sep; 169(37):3085-7. PubMed ID: 17877954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacogenetics and pharmacogenomics in oncology therapeutic antibody development.
    Yan L; Beckman RA
    Biotechniques; 2005 Oct; 39(4):565-8. PubMed ID: 16235569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antineoplastic agents targeting tyrosine kinases].
    Guren TK; Christoffersen T; Thoresen GH; Wisløff F; Dajani O; Tveit KM
    Tidsskr Nor Laegeforen; 2005 Nov; 125(22):3115-9. PubMed ID: 16299568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of receptor tyrosine kinases in gastric cancer: new targets for a selective therapy.
    Becker JC; Muller-Tidow C; Serve H; Domschke W; Pohle T
    World J Gastroenterol; 2006 Jun; 12(21):3297-305. PubMed ID: 16733844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoclonal antibody therapy.
    O'Mahony D; Bishop MR
    Front Biosci; 2006 May; 11():1620-35. PubMed ID: 16368542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Molecular target therapy for malignant tumors].
    Nihon Naika Gakkai Zasshi; 2005 Feb; 94 Suppl():76-80. PubMed ID: 15796061
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.